SpineGuard Expands PediGuard Lineup with Three New Models in China
Event summary
- SpineGuard launched three new PediGuard® models—Curved and XS versions—at the 2026 Chinese Scoliosis Annual Meeting in Nanjing.
- The new models were showcased at XinRong Medical’s booth, generating strong surgeon interest, particularly for the curved version.
- First evaluation surgeries in China using the new models have been completed successfully.
- Professor Qiu hosted the congress, reinforcing SpineGuard’s collaboration with its Chinese commercial partner.
The big picture
SpineGuard’s expansion into the Chinese scoliosis surgery market aligns with broader trends in medical device innovation, where precision and safety are critical. The company’s DSG technology is gaining traction globally, positioning it as a key player in skeletal implant guidance systems. With over 110,000 procedures secured worldwide, SpineGuard is well-positioned to capitalize on the growing demand for advanced surgical solutions.
What we're watching
- Market Penetration
- Whether SpineGuard can sustain momentum in China following the successful launch of its new PediGuard models.
- Technology Adoption
- The pace at which surgeons adopt the Curved and XS versions for complex scoliosis surgeries.
- Strategic Collaboration
- How deepening ties with XinRong Medical will impact SpineGuard’s market share in China.
Related topics